文献速递免疫规划传染病防控与疫情报告

四组分B群脑膜炎球菌疫苗后肾病综合征监测信号的流行病学调查

Nephrotic syndrome following four-component meningococcal B vaccination: Epidemiologic investigation of a surveillance signal.
PubMed 文献 · Vaccine · 2019-07-12

2014年加拿大魁北克某地区为约49,000名2月龄至20岁人群接种四组分B群脑膜炎球菌疫苗,主动上市后监测发现数例肾病综合征。调查确认4例接种儿童发病,1-9岁接种者接种后一年NS发病率为17.7/10万,住院率较接种前八年升高8.3倍(95%CI 1.1-62.0;p=0.039),但置信区间宽,不能排除偶然聚集。

要点

  • 4CMenB接种后主动监测发现肾病综合征病例增多,共确认4例接种儿童。
  • 1-9岁接种者接种后一年NS发病率17.7/10万,住院率较接种前八年升高8.3倍。
  • 时间关联可能由其他原因或罕见事件偶然聚集解释,需其他辖区监测验证。

核心结论

  • 主动安全监测发现4CMenB接种后肾病综合征发病率意外增加,共确认4例接种儿童病例。
  • 接种者风险升高置信区间宽,下限包含或略高于无效值,统计学意义无或临界。
  • 时间关联可能由其他原因或与接种无关的罕见事件偶然聚集解释。
  • 需在给1-9岁儿童接种4CMenB的其他辖区开展监测以确认或反驳潜在关联。

研究设计与样本

  • 主动疫苗安全监测通过电子方式开展,参与者在每剂后7天和末剂后6个月完成在线问卷。
  • 从省级住院和急诊数据库补充检索肾病综合征病例。
  • 2014年5月起在加拿大魁北克高地方性流行区对约49,000名2月龄至20岁人群开展4CMenB大规模接种。

主要发现

  • 首剂接种后一年内,2-5岁接种儿童中确认4例NS(3例住院),发病在接种后数月。
  • 4例均无肾活检,基于年龄和对激素反应推测诊断为特发性NS。
  • 1-9岁接种儿童接种后一年NS发病率为17.7/10万(每5650名接种者1例)。
  • NS住院率较同期全省其他地区高3.6倍(95%CI 0.7-11.8;p=0.12)。
  • NS住院率较接种前八年该地区高8.3倍(95%CI 1.1-62.0;p=0.039)。

临床怎么用

  • 对1-9岁儿童接种4CMenB后应关注肾病综合征相关症状,主动监测有助于发现罕见信号。
  • 当前证据不足以确立因果关联,临床决策应结合个体风险评估并继续报告不良事件。

局限性

  • 病例无肾活检,特发性NS为推测诊断。
  • 风险估计置信区间宽,统计学意义无或临界,不能排除偶然聚集。
  • 需其他辖区监测数据以确认或反驳潜在关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In May 2014, a mass vaccination campaign with four-component meningococcal serogroup B (4CMenB) vaccine was launched in a localized region of Quebec, Canada experiencing high invasive meningococcal B disease endemicity. Active post-marketing surveillance identified several cases of nephrotic syndrome (NS) among ∼49,000 vaccinated individuals aged 2 months to 20 years. We report the epidemiologic investigation of this potential vaccine safety signal. METHODS: Active vaccine safety surveillance was conducted electronically, with participants completing an online questionnaire prompted at 7 days after each dose and 6 months following the last dose. Additional NS cases were sought from provincial hospitalization and emergency room databases. RESULTS: In the year following the first dose of 4CMenB vaccination, four confirmed NS cases (three hospitalized) were identified among vaccinated children 2-5-years-old with onset several months post-vaccination. None had renal biopsy but given their age, and positive response to steroids, idiopathic NS was presumptively diagnosed. Among vaccinated children 1-9-years-old, the NS incidence in the year post-vaccination was 17.7 per 100,000 (1 per 5650 vaccinees) with an NS hospitalization rate (i.e. excluding the outpatient case) that was 3.6-fold higher (95%CI = 0.7-11.8; p = 0.12) than the rest of the province for the same period, and 8.3-fold greater (95%CI = 1.1-62.0; p = 0.039) than during the eight years preceding the immunization campaign in the affected region. CONCLUSION: Active safety surveillance identified an unexpected increase in NS incidence following 4CMenB vaccination. Further epidemiological investigation identified four vaccinated cases in total over a 12 month period of follow up. The greater risk in vaccinees had wide confidence intervals with he lower limit including or just above the nul value, an observation with no or marginal statistical significance. The temporal association with vaccination may be explained by other causes and/or chance clustering of a rare event unrelated to vaccination. To confirm or refute a potential link to vaccination, surveillance in other jurisdictions administering 4CMenB to children 1-9-years-old is needed.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. De Serres G, Billard MN, Gariépy MC, et al. Nephrotic syndrome following four-component meningococcal B vaccination: Epidemiologic investigation of a surveillance signal. Vaccine. 2019. PMID: 31307873. doi:10.1016/j.vaccine.2019.07.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。